Key result
Insulin resistance and systemic inflammation synergistically linked to higher CV event risk in diabetic CCS.
Why the study?
Does the combination of insulin resistance and systemic inflammation increase the risk of cardiovascular events in diabetic CCS patients?
Does the combination of insulin resistance and systemic inflammation increase the risk of cardiovascular events in diabetic CCS patients?
Combining TyG and hsCRP can help identify high-risk diabetic CCS patients, as insulin resistance and systemic inflammation synergistically increase cardiovascular risk.
May aid risk stratification with TyG and hsCRP in diabetic CCS; leaves open whether targeting inflammation improves outcomes.
< 0.001). In diabetic CCS patients, insulin resistance and systemic inflammation synergically increased the risk of cardiovascular events, and systemic inflammation partially mediated the association between insulin resistance and clinical outcomes. Combining TyG and hsCRP can help identify high-risk patients. Controlling inflammation in patients with insulin resistance may bring added benefits.
No takes yet. Share an insight, caveat, or question.
Li et al. (2023) studied this question. Insulin resistance and systemic inflammation synergistically increased the risk of cardiovascular events in patients with diabetic chronic coronary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: